Menu
Not yet recruiting NCT07071571

New Intraoperative Nerve Monitoring Device

No phase Interventional Thryoid Cancer parathyrıoid Adenoma

For patients and families

In plain language

Fill the application

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: neuromonitoring.
Who it may be relevant to
Registry conditions: Thryoid Cancer, parathyrıoid Adenoma. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Evaluation of the Usability and Safety of the Newly Developed Piezoelectric Sensor Intraoperative Nerve Monitoring Device in Thyroid and Parathyroid Surgery: A Pilot Study

Overview

This study is testing a new device developed to protect the recurrent laryngeal nerve, which is at risk of damage during thyroid and parathyroid surgeries.

Detailed description

This study is testing a new device developed to protect the recurrent laryngeal nerve, which is at risk of damage during thyroid and parathyroid surgeries. Such devices are still used in surgical routine, but research has been initiated on this subject due to the higher sensitivity and reliability of this new device.

Interventions

  • Device neuromonitoring
    new neuromonitorin device will use

Primary outcome measures

  • recurrent nerve identification [Time frame: introperatively]

Eligibility criteria

Inclusion criteria

  • Age 18-70, diagnosis of benign/malignant thyroid disease, informed consent

Exclusion criteria

  • History of previous nerve injury, concomitant neurological disorder

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07071571 · 111.023 · No any fund

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗